CytoReason, a leader in developing computational disease models for predictive insights, announced it secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific.
CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available for research use only (RUO). IPS is the first offering of a larger immunotherapy-based portfolio being developed at Tempus to bring next-generation algorithmic diagnostics to...
Circle Cardiovascular Imaging, the global leader in AI-driven cardiovascular imaging solutions, announced that Erkan Akyuz has been appointed Chief Executive Officer, effective August 5, 2024. He will succeed Circle co-founder and CEO Greg Ogrodnick, who is stepping down after successfully leading the Company for more than 16 years.
Akyuz brings extensive...
Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced the launch of the LuxSit™ Pro family of products, the world's smallest and first commercially-available de novo luciferases, which are light-emitting enzymes that use...
Mendel AI, a leader in clinical AI for the life sciences industry, announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements.
By joining NVIDIA Inception, Mendel will receive access to NVIDIA’s industry-leading technology, including the latest NVIDIA NIM inference microservices to accelerate Mendel's Hypercube AI solution,...
Digital workflows help to improve diagnostic accuracy and efficiency by integrating pathology into broader precision diagnostic systems and IT infrastructure
Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort more than in any other area of medicine. It involves a multidisciplinary team of oncologists, pathologists,...
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, announced that it has raised €6.2 million in a seed funding round. The investment was led by Kurma Partners and Heal Capital.'
This funding will enable Spotlight Medical to...
Cognizant and Yseop, a leading artificial intelligence (AI) software company, have announced a plan to partner to help accelerate and scale the delivery of scientific content in the biopharma industry through generative AI. By utilising Yseop Copilot to transform medical writing in life sciences, the companies are hoping to enhance...
Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement.
BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform.
Sanyou Bio is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs.
Both parties will leverage their...
AUSTIN, Texas, July 10, 2024 -- Oracle has introduced advanced features in its AI-powered Oracle Argus and Safety One Intake solutions to support life science organizations in managing regulatory requirements and increased adverse event case volumes. These new enhancements are designed to boost efficiency, enhance data privacy, and improve...
